IE SPEAKS

RBI expects FY2027 growth at 6.7%, inflation at 5%

The first quarter GDP is expected at 7 per cent, while it is expected to be 6.4 per cent in the second quarter. RBI now...

RBI keeps repo rate unchanged, awaits more clarity

“Any such action would also have to consider the need for recalibration of policy rates in line with the evolving growth-inflation dynamics, especially the...

RBI decision: Likely status quo, all eyes on future direction

The domestic economic fundamentals remain resilient, but inflationary pressures have heightened amid the persistent stand-off in the Gulf region. Upside risk to inflation, fiscal and...

Inklings – Growth, greening, innovation…

The election fever has caught on fire across India. With 968 million voters registered until now, it will be one of the most important...

R&D – Focussing on tier-2 and 3 cities is necessary…

Rajesh Subramaniam(RS) founded embedUR in 2004 and the company is known for its cutting edge products serving clients who are among the Fortune 500...

Imperative need to ramp up R&D

After finding a global voice and position, the youngest nation in the world has shifted its focus, rightly towards research and innovation. The interim...

Insurance – Predatory practice to lure customers

Insurance sector has been under the scrutiny of government agencies for some time now. First the GST authorities raised a huge demand running into...

Technology – Orion Innovation to double India operations by 2026…

Looking to double operations by 2026 in India, Jaepy Kurian, Head of Delivery for India and Arun Paul, Head of Asia Pacific Human Resources,...

TN GIM 2024 – Investments worth Rs 664,180 crore with job opportunities to more than 26 lakh

The Tamil Nadu Global Investors Meet 2024 came to a close with MoUs worth Rs 664,180 crore signed, promising job opportunities for more than...

Inklings – A year of transition…

2023 has been truly eventful in all senses. Several sectors have witnessed major changes, that would spearhead them through the next era of growth....

Biologics-based drugs at the fore – Supriya Kashikar, CEO, GeNext Genomics Pvt Ltd.

The biotech industry is witnessing unprecedented demand on many fronts. Change is taking place at the speed of light. AI and ML are revolutionising...

Stay in touch:

255,324FansLike
128,657FollowersFollow
97,058SubscribersSubscribe

Newsletter

Don't miss

RBI expects FY2027 growth at 6.7%, inflation at 5%

The first quarter GDP is expected at 7 per...

RBI keeps repo rate unchanged, awaits more clarity

“Any such action would also have to consider the...

RBI decision: Likely status quo, all eyes on future direction

The domestic economic fundamentals remain resilient, but inflationary pressures...

The Sustainable and Scalable World of Net Zero

As I reflect on the enthralling path of Environmental...

A biography on SNN Sankaralinga Iyer

The biography was authored by veteran journalist K Balakumar....